Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00998205 · ClinicalTrials.gov registry record · NA
Early Diagnosis of Diastolic Dysfunction and Reliability of DSE in Detecting Stress Diastolic Dysfunction
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT00998205 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 16 participants.
The verdict
NCT00998205, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The heart becoming "stiff" due to increased fibrous tissue or decreased elasticity of the heart tissue is one of the earliest changes caused by heart failure. These changes can be detected by simple non-invasive echocardiogram techniques. However, these techniques usually detect the increased "stiffness" of the heart only after it has progressed to a significant extent. The investigators hypothesize that if they stress the heart using a Dobutamine infusion and measure the filling pressure using echocardiogram, it will provide them with tools to identify these changes earlier.
Interventions
- DRUG Dobutamine stress echo (DSE)
- DRUG Atropine bolus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00998205
The ClinicalTrials.gov registry entry for NCT00998205 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dobutamine stress echo (DSE) is the first listed.
NCT00998205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00998205 about?
NCT00998205 is a clinical study titled "Early Diagnosis of Diastolic Dysfunction and Reliability of DSE in Detecting Stress Diastolic Dysfunction". The heart becoming "stiff" due to increased fibrous tissue or decreased elasticity of the heart tissue is one of the earliest changes caused by heart failure. These changes can be detected by simple non-invasive echocardiogram techniques. However, these techniques usually detect the increased "stiff...
What is the current status of trial NCT00998205?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2008-06. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00998205?
The interventions under investigation include: Dobutamine stress echo (DSE) (DRUG), Atropine bolus (DRUG).
Who is sponsoring clinical trial NCT00998205?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.